Wimal Pathmasiri, PhD
- Preterm neonatal urinary renal developmental and acute kidney injury metabolomic profiling: an exploratory study
- Disposition of intravenously or orally administered silver nanoparticles in pregnant rats and the effect on the biochemical profile in urine.
- Serum Metabolomic Profiles in Neonatal Mice following Oral Brominated Flame Retardant Exposures to Hexabromocyclododecane (HBCD) Alpha, Gamma, and Commercial Mixture
Wimal Pathmasiri, PhD is an Assistant Professor at the University of North Carolina at Chapel Hill’s Nutrition Research Institute (NRI). An overarching goal of Dr. Pathmasiri’ s research includes understanding the links between exposures (diet, constituents in natural projects, environmental chemicals, drugs), microbial metabolism, and human health. He was worked with the Sumner-Lab for over 12 years, as the director of a technology core for the NIH Common Fund Eastern Regional Comprehensive Metabolomics Resource Core (ERCMRC), and as a co-investigator in the North Carolina Human Health Exposure Analysis Resource Untargeted Analysis Laboratory (NC HHEAR UAL). Dr. Pathmasiri develops and applies metabolomics to reveal metabolic pathway perturbations associated with disease states, therapeutic treatments, and environmentally relevant exposures. He has contributed to research in the areas of cancer, childhood obesity, early-life exposure to antibiotics, environmental exposure, kidney disease, osteoarthritis, rare diseases, and toxicology. Dr. Pathmasiri earned a BSc and MPhil from the University of Colombo, Sri Lanka, and a Licentiate of Philosophy from the Uppsala University, Sweden. He earned a PhD in Chemistry from Uppsala University and conducted postdoctoral research at UNC Chapel Hill, and at RTI International.